101: Biotechnology and Healthcare: A New Dawn? With Bob Bradway, CEO of Amgen
Money Maze Podcast
00:00
The Importance of Genetics in Drug Discovery
genetics going to be a third of new formulations that you expect to find? Well what I would say Simon is that we do expect it will be very important and if we look at our pipeline today something on the order of two-thirds of our molecules in our pipeline outside of cancer. It's certainly higher risk when you're trying to innovate and develop first-in-class medicine so you can't rely on the data that others have generated through time to show that the outcome you're intending to achieve is likely to happen.
Transcript
Play full episode
